Federal Trade Commission sues to block acquisition of Cencora's MWI Animal Health
The proposed $3.5 billion acquisition would raise costs for veterinary clinics, increase prices for pet owners, and reduce the quality of services, the FTC says.

The Federal Trade Commission and more than a dozen states have filed a lawsuit seeking to block the merger of two veterinary products distributors, including one owned by Conshohocken-based Cencora Inc.
The FTC and states allege that Maine-based Covetrus Inc.’s proposed $3.5 billion acquisition of Cencora’s MWI Animal Health would raise costs for veterinary clinics, increase prices for pet owners, and reduce the quality of services.
Covetrus and MWI are two of the largest veterinary clinic distributors in the country, according to the plaintiffs. They supply products including pharmaceuticals, vaccines, gloves, and syringes.
“Veterinarians and millions of American pet owners benefit when veterinary distributors compete by offering lower prices and better service,” Daniel Guarnera, director of the FTC’s Bureau of Competition, said in a statement.
“This transaction will reduce competition in an already concentrated market and drive up prices for veterinarians and their customers,” he said.
A bipartisan coalition of 13 states — not including Pennsylvania or New Jersey — joined the complaint, which was filed under seal in federal court in Manhattan on Friday.
“A trip to the vet should never break the bank,” New York Attorney General Letitia James, a Democrat, said in a statement. “Pet owners are already paying enormous prices for care, and this merger would threaten to drive costs even higher.”
A spokesperson for wholesale drug distributor Cencora, a publicly traded company formerly known as AmerisourceBergen, didn’t immediately return a request for comment Monday.
Covetrus — a subsidiary of private equity firms Clayton, Dubilier & Rice LLC and TPG — said the FTC’s case “relies on a narrow and outdated view of the market.”
“Clinics today choose freely from numerous manufacturers and distributors to meet their needs, and online platforms have ensured that veterinarians have complete flexibility across a wide range of suppliers,” the company said in a statement.
Under the proposed transaction, announced in February, Cencora would receive $1.25 billion in cash, $800 million in preferred equity, and $1.45 billion in common equity — retaining a 34% common equity stake in the combined company.
“This transaction positions MWI for success with a partner strategically focused on and dedicated to animal health, while allowing Cencora to further invest in our key growth priorities,” Cencora CEO Robert Mauch said at the time.
Cencora reported $337 billion in revenue for the fiscal year that ended in September. It had $3.5 billion in net income.
The FTC said the complaint seeks a permanent injunction to block the proposed merger.

























